
What happened
Google DeepMind, Meta, and Isomorphic Labs are jointly investing $300 million into Biohub, the nonprofit founded by Mark Zuckerberg and Priscilla Chan, part of a $1.8 billion initiative to build AI datasets for a 'virtual cell.'
Why it matters
The partners say the datasets could let researchers 'ask, predict, and answer biological questions digitally,' which Biohub's head of science, Alex Rives, says could dramatically accelerate scientific discovery by allowing experiments to be performed digitally.
What to watch
Whether a virtual cell can actually be built hinges on coordinated data generation at national and international scale, which Rives describes as a requirement, so the work is likely to depend on sustained commitments from the partners involved.
WHO IT HITSThis lands on biomedical researchers and drug-discovery teams, who would gain shared AI datasets for simulating experiments rather than running them in a lab, and on the nonprofit research organizations that depend on such funding.
Summaries like this, in your inbox every morning.
Biohub was founded in 2016 with the aim of combating diseases, and its bet is that an accurate predictive model of biology can let scientists run experiments digitally instead of in the lab. The new $300 million from Google DeepMind, Meta, and Isomorphic Labs sits inside a $1.8 billion initiative to build the AI datasets such a model would need, and it arrives alongside public support: the US Department of Energy is putting in more than $500 million over the next five years, while the National Institutes of Health is contributing datasets, repositories, and knowledge bases from prior federal investment totaling over $500 million.
What ties these contributions together is scale. Alex Rives, Biohub's head of science, says creating a virtual cell will require coordinated data generation at national and international scale, which is the stated reason these partners are coming together. In other words, the money is not just funding a model but a shared data effort that no single lab or company is expected to assemble alone.
The test, based on Rives's framing, is whether that coordination actually materializes across countries and institutions; the datasets, rather than the dollars, are likely to determine how far the virtual cell gets. For the companies involved, the payoff would be a faster path to disease prevention and management, though that depends on whether the data generation effort holds together.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Kore.ai Inc. launched Autoloop, which adjusts AI agents toward goals customers set for task completion, busine…
In its Q3 2026 investor letter, the Artisan Developing World Fund said Micron Technology, Inc

SpaceX is reportedly raising $40 billion in debt to buy Nvidia chips, according to Semafor

In August, DoorDash emailed Bay Area restaurants warning they may be listed on Bites without consent, with ter…

TechCrunch Disrupt 2026 announced the full lineup of interactive roundtables for its October 13-15 event at Mo…

OpenAI launched Dots, an always-on personal AI agent with its own cloud computers that can connect to everyday…
